Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernovartis.com
English RSS Feed
Get the latest updates from English RSS Feed directly as they happen.
Follow now 75 followers
Latest posts
Last updated 11 days ago
New Novartis ESC data highlights strength of cardiovascular portfolio
11 days ago
New Novartis ESC data highlights strength of cardiovascular portfolio arcticnovartis Mon, 08/18/2025...
Novartis ianalumab Phase III trial meets primary endpoint in ITP, demonstrating statistically significant improvement in time to treatment failure
17 days ago
Novartis ianalumab Phase III trial meets primary endpoint in ITP, demonstrating statistically...
Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease
18 days ago
Novartis announces both ianalumab Phase III clinical trials met primary endpoint in...
Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the company
about 1 month ago
Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires...
Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance
about 1 month ago
Novartis reports strong Q2 with double-digit sales growth and core margin expansion...
Novartis verzeichnet ein starkes zweites Quartal mit zweistelligem Umsatzwachstum und erhöhter Kerngewinnmarge; Prognose für das operative Kernergebnis im Geschäftsjahr 2025 angehoben
about 1 month ago
Novartis verzeichnet ein starkes zweites Quartal mit zweistelligem Umsatzwachstum und erhöhter Kerngewinnmarge...
Novartis receives approval for first malaria medicine for newborn babies and young infants
about 2 months ago
Novartis receives approval for first malaria medicine for newborn babies and young...
Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA)
about 2 months ago
Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant...
Novartis completes acquisition of Regulus Therapeutics
2 months ago
Novartis completes acquisition of Regulus Therapeutics arcticnovartis Wed, 06/25/2025 - 15:19 Read...
Novartis announces expiration of Regulus Therapeutics tender offer
2 months ago
Novartis announces expiration of Regulus Therapeutics tender offer arcticnovartis Wed, 06/25/2025 -...
Novartis announces expiration of HSR waiting period of Regulus Therapeutics tender offer
2 months ago
Novartis announces expiration of HSR waiting period of Regulus Therapeutics tender offer...
Novartis Fabhalta® shows statistically significant and clinically meaningful improvements in hemoglobin in new population of patients with PNH
3 months ago
Novartis Fabhalta® shows statistically significant and clinically meaningful improvements in hemoglobin in...